AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,083,000 | -53.3% | 394,539 | -37.1% | 0.00% | -33.3% |
| Q2 2019 | $23,734,000 | -23.1% | 626,881 | -20.7% | 0.00% | -40.0% |
| Q1 2019 | $30,860,000 | +62.4% | 790,868 | -11.3% | 0.01% | +66.7% |
| Q4 2018 | $19,000,000 | -79.3% | 891,181 | -61.5% | 0.00% | -76.9% |
| Q3 2018 | $91,635,000 | +2.6% | 2,314,604 | -0.9% | 0.01% | -7.1% |
| Q2 2018 | $89,270,000 | +64.1% | 2,336,304 | +29.1% | 0.01% | +55.6% |
| Q1 2018 | $54,393,000 | +12.6% | 1,810,088 | +17.1% | 0.01% | +12.5% |
| Q4 2017 | $48,293,000 | +198.1% | 1,545,377 | +167.2% | 0.01% | +166.7% |
| Q3 2017 | $16,199,000 | +40.7% | 578,342 | -3.9% | 0.00% | +50.0% |
| Q2 2017 | $11,515,000 | +20.6% | 601,942 | +7.4% | 0.00% | 0.0% |
| Q1 2017 | $9,549,000 | -7.0% | 560,397 | -3.1% | 0.00% | 0.0% |
| Q4 2016 | $10,267,000 | +2.4% | 578,597 | -0.2% | 0.00% | 0.0% |
| Q3 2016 | $10,028,000 | – | 579,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |